Clinical Aspects of Systemic Vasculitis in Adults

Andrews M. Edmunds M. Campbell A. Walls J. Feehally J. Systemic vasculitis in the 1980s — is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Phys Lond 1990; 24: 284–88.

Scott D. G. I. Vasculitis. Topical Reviews (Series 2), No. 12. London: British Society for Rheumatology, 1989.

Hunder G G Arend W P Bloch D A . The American College of Rheumatology 1990 Criteria for the Classification of Vasculitis. Arthritis Rheum 1990; 33: (8) 1065–67.

Zeek P. M. Periarteritis nodosa. A critical review. Am J Clin Pathol 1952; 22: 777–90.

Alarcon-Segovia D. Brown A. L. Classification and aetiologic aspects of necrotising angitides. Mayo Clin Proc 1964; 39: 205–22.

Lie J. T. Classification and immuno-diagnosis of vasculitis — a new resolution or promises unfulfilled? Editorial. J Rheumatol 1988; 15: 5.

Cupps T R Fauci A. S. The vasculitides. Philadelphia: WB Saunders, 1981; 50.

Travers R L Allison D J Brettle R P Hughes G. R. V. Polyarteritis nodosa: A clinical and angiographic analysis of 17 cases. Semin Arthritis Rheum 1979; 8: 184–99.

Easterbrook J. S. Renal and hepatic microaneurysms: Report of a new entity simulating polyarteritis nodosa. Radiology 1980; 137: 629.

Bacon P A Luqmani R A Scott D G I Adu D. Immunopharmacology of vasculitic syndromes. In: Rogstad Endresa Forre eds. Immunopharmacology in autoimmune disease and transplantation. New York: Plenum Press, 1992: 273–89.

Scott D. G. I. Vasculitis. In: Scott J T ed. Copeman's textbook of the rheumatic diseases, sixth edition. Edinburgh: Churchill Livingstone, 1986: 1292–324.

Cohen R D Conn D L Ilstrup D. M. Clinical features, prognosis and response to treatment in polyarteritis. Mayo Clin Proc 1980; 55: 146.

Davies D J Moran J E Niall J F Ryan G. B. Segmental necrotising glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology? Br Med J 1982; 285: 606.

Van der Woude Rasmussen F J Lobatto S. . Antibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; i: 425–29.

Savage C O Winerals C G Jones S. Marshall P D Lockwood C. M. Prospective study of radio-immunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1987; i: 1389–93.

Nolle B. Speeks U. Ludemann J. . Anticytoplasmic antibodies: Their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989; 111: 28–40.

Wilk A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989; 97: (suppl 6): 12–13.

Falk R. Jennette J. C. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis. N Engl J Med 1988; 18: 1651–57.

Rasmussen N. Sjolin C. Isaksson B. Bygren P. Wieslander J. An ELISA for the detection of antineutrophil cytoplasm antibodies (ANCA). J Immunol Methods 1990; 127: 139–45.

Savage C O S Tizard J. Jayne D. . Antineutrophil cytoplasmic antibodies in Kawasaki disease. Arch Dis Child 1989, 64: 28–36.

Scott D G I Sharrack B R Webb F W S Lockwood C. M. Antineutrophil cytoplasmic antibodies and rheumatoid vasculitis. Br J Rheumatol 1990; XXIX: 44 (Abstract).

Harrison D J Simpson R. Kharbanda R. . Antibodies to neutrophil cytoplasmic antigens in Wegener's granulomatosis and other conditions. Thorax 1989; 44: 373–77.

Finnegan M J Jayne D J Neill S. Wise A. Hodson M. E. Cutaneous and systemic vasculitis in cystic fibrosis. Thorax 1989; 44: 314–16.

Jennette J C Falk R. J. Diagnostic classification of anti-neutrophil cytoplasmic antibody associated diseases. Am J Kidney Dis 1991; 2: 184–87.

Editorial. Factor VIII related antigen and vasculitis. Lancet 1988; i: 1203–204.

Fahey J. Leonard E. Churg J. Godman G. C. Wegener's granulomatosis. Am J Med 1954; 17: 168.

Godman G C Churg J. Wegener's granulomatosis: Pathology and review of the literature. Arch Pathol 1954; 58: 533–53.

Fauci A S Haynes B F Katz P. Wolff S. M. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76–85.

Leavitt R Y Fauci A. S. Pulmonary vasculitis. Am Rev Respir Dis 1986; 134: 149–66.

Balow J. E. Renal vasculitis. Nephrology forum. Kidney Int 1985; 27: 954–64.

Hoffman G S Kerr G S Leavitt R Y . Wegener's granulomatosis: An analysis of 158 patients. Ann Intern Med 1992; 116: 488–98.

Travis W D Hoffman G S Leavitt R Y Pass H I Fauci A. S. Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 1990; 14: 112–25.

Fauci A S Wolff S. M. Wegener's granulomatosis: Studies in 18 patients and a review of the literature. Medicine (Baltimore) 1973; 52: 535–61.

Wolff S M Fauci A S Horn R G Dale D. C. Wegener's granulomatosis. Ann Intern Med 1974; 81: 513–25.

Scott D G I Bacon P. A. Intravenous cyclophosphamide plus methylprednisolone in the treatment of systemic rheumatoid vasculitis. Am J Med 1984; 76: 377–84.

Anderson C L Stravides A. Rapidly progressive renal failure as the primary manifestation of Wegener's granulomatosis. Am J Med Sci 1978; 275: 109–12.

Woodworth T G Abudo J G Austin H A III Esparza A. Severe glomerulonephritis with late emergence of classic Wegener's granulomatosis. Medicine (Baltimore) 1987; 66: 181–91.

Luqmani R A Adu D. Emery P. Michael J. Howie A J Bacon P. A. Is limited upper respiratory tract Wegener's different from classical Wegener's granulomatosis? Br J Rheumatol 1989; (Abstract). XXVIII (suppl 2): 70.

De Remee R A McDonald T J Weiland L. H. Wegener's granulomatosis: Observation and treatment with anti-microbial agents. Mayo Clin Proc 1985; 60: 27–32.

Kussmaul A. Mair R. Uclereine bisher nicht beshriebene eigenthumliche arterien Erkrankeng (Periarteritis Nodosa), die mit Morbus Brightie und rapid Fortschrei tender all gemeiner Muskellahmung Einhergeht. Dtsch Arch Clin Med 1966; 1: 484.

Ball J. Rheumatoid arthritis and polyarteritis nodosa. Ann Rheum Dis 1954; 13: 277.

Alexander E L Arnett F C Provost T T . Sjögren's syndrome: Association of anti-Ro (SSA) antibodies with vasculitis, haematologic abnormalities and serologic hyper-reactivity. Ann Intern Med 1983; 98: 155.

Gorevic P D Kassab H J Levo Y. . Mixed cryoglobulinemia: Clinical aspects and long term follow up of 40 patients. Am J Med 1980; 69: 287.

Treppo C G Auckerman A J Bird R C . The role of circulating hepatitis B antigen/antibody immune manifestations in polyarteritis nodosa. J Clin Pathol 1974; 27: 863.

Pickering G. Bywaters E G L Danielli J F . Treatment of polyarteritis nodosa. Results after 3 years: Report to the Medical Research Council by the Collagen Disease and Hypersensitivity Panel. Br Med J 1960; 1: 1399–400.

Lieb E S Restiro C. Paulus H. R. Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med 1979; 67: 941–47.

Scott D G I Bacon P A Tribe C R . Systemic vasculitis in a district general hospital 1972–1980. Clinical and laboratory features, classification and prognosis of 80 cases. Q J Med 1982; 51: 292–311.

Scott D G I Bacon P A Tribe C. R. Systemic rheumatoid vasculitis: A clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981; 60: 288–97.

Vollerstern R S Conn D L Ballard D. J. Rheumatoid vasculitis: Survival and associated risk factors. Medicine (Baltimore) 1986; 65: 365–75.

Scott D G I Bacon P A Bothamley J E Allen C. Elson C J Wallington T. Plasma exchange in rheumatoid vasculitis. J Rheumatol 1981; 8: 433–39.

Kemper J W Baggenstoss A H Slocumb C. H. The relationship of therapy with cortisone to the incidence of vascular lesions in rheumatoid arthritis. Ann Intern Med 1957; 46: 831–51.

Baggenstoss A H Shick R M Polley H. F. The effect of corticosteroids on the lesions of pollyarteritis nodosa. Am J Pathol 1951; 27: 537.

Conn D L Tomkins R B Nichols W. L. Glucocorticoids in the management of vasculitis – a double edged sword [Editorial]. J Rheumatol 1988; 15: 1181.

Upchurch K S Heller K. Bress N. M. Low dose methotrexate therapy for cutaneous vasculitis and rheumatoid arthritis. J Am Acad Dermatol 1987; 17: 355–59.

Churg J. Strauss L. Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 1951; 27: 277–301.

Lanham J G Elkon K B Pusey C D Hughes G. R. V. Systemic vasculitis in asthma and eosinophilia: A clinical approach to the Churg–Strauss syndrome. Medicine (Baltimore) 1984; 63: 65–81.

Chumbley L C Harrison R A De Reunee R. A. Allergic granulomatous angiitis (Churg–Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 1977; 52: 477–84.

Chow C C Li E K M MacMoune L. A. I. F. Allergic granulomatosis and angiitis (Churg–Strauss syndrome): Response to pulse IV cyclophosphamide. Ann Rheum Dis 1989; 48: 605–608.

Guillevin L. Le Thi Huong D U Godeau P. . Clinical findings and prognosis of polyarteritis nodosa and Churg–Strauss angiitis: A study in 165 patients. Br J Rheumatol 1988; 27: 258–64.

O'Duffy J D Bowles C A O'Fallon W. M. The immunosuppressive therapy of Behçet's disease with emphasis on chlorambucil. In: Recent advances in Behçet's disease. Congress and symposium series, No. 103. London: RSM Services, 1986: 301–306.

Lakhanpal S. Tani K. Lie J T . Pathologic features of Behçet's syndrome. A review of Japanese autopsy registry data. Hum Pathol 1985; 16(8): 790–95.

Le Thi Huong D U Fain O. Wechsler B. . Interet des ‘bolus’ de cyclophosphamide dans la maladie de Behçet. Experience de 17 cas. Presse Med 1990; 19: 1355–58.

Nussenblatt R B Palestine A G Chan C. C. Effectiveness of cyclosporin therapy for Behçet's disease. Arthritis Rheum 1985; 28: 671–79.

Kawasaki T. Kosaki F. Okawa S. . A new infantile acute febrile mucocutaneous lymph node syndrome (MCNS) prevailing in Japan. Paediatrics 1974; 54: 271–76.

Shulman S T Rowley A. H. Does Kawasaki disease have a retroviral aetiology. Lancet 1986; ii: 545.

Leung D. Cotran R S Kurt-Jons E. . Endothelial cell activation and interleukin 1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989; ii: 1298–302.

Neuburger J W Takahashi M. Burn J. . The treatment of Kawasaki syndrome with intravenous gamma-globulin. N Engl J Med 1986; 315: 341.

Dillon M. J. Diagnosis and clinical management of childhood vasculitic disease. Vascular Medicine Review 1993; vmr-4: 133–43.

McMillan G. C. Diffuse granulomatous aortitis with giant cells associated with partial rupture and dissection of aorta. Arch Pathol 1950; 49: 63.

Hutchinson J. Disease of the arteries. On a peculiar form of thrombotic arteritis of the aged which is sometimes productive of gangrene. Arch Surg 1890; 1: 323–29.

Horton B T Magath T B Brown G. E. Arteritis of the temporal arteries. Arch Intern Med 1933; 53: 400–409.

Salvarani C. Macchioni P. Sizi F. . Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in Northern Italy. Arthritis Rheum 1991; 34: 351–56.

Nordborg E. Bengstsson B. A. Epidemiology of biopsy proven giant cell arteritis (GCA). J Intern Med 1990; 227: 233–36.

Silman A. Symposia reports on polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1988; 27: 310–16.

Osnes M. Lassen J. Artritta og polymyalgler ved yersinia enterocolitica infeksjoner. Tidsskr Nor Laegeforen 1974; 94: 225–28.

Dasgupta B. Duke O. Kyle V. McFarlane D G Hazleman B L Panayi G. S. Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis — a sequential study. Ann Rheum Dis 1988; 46: 747–49.

Hazleman B L Goldston P A Voak D. Association of polymyalgia rheumatica and giant cell arteritis with HLAB8. Br Med J 1977; 2: 989.

Hunder G G Allen G. L. Giant cell arteritis: A review. Bull Rheu Dis 1978–79; 29: 980.

Ellis M E Ralston S. The ESR in the diagnosis and management of polymyalgia rheumatica and giant cell arteritis syndrome. Am Rheum Dis 1983; 42: 168–70.

Kyle V. Humm G. Causton T E Hazleman B. L. CRP and ESR in polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1987; 26 (suppl): 65.

Jundt J. Mock D. Temporal arteritis with normal erythrocyte sedimentation rates presenting as occipital neuralgia. Arthritis Rheum 1991; 34: 217–19.

Gallagher P. Jones K. Immunohistochemical findings in cranial arteritis. Arthritis Rheum 1982; 25: 75–79.

Behn A R Perera T. Myles A. B. Polymyalgia rheumatica and corticosteroids: How much for how long? Ann Rheum Dis 1983; 42: 374–78.

Kyle V. Hazleman B. L. H. The clinical and laboratory cause of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) Br J Rheumatol 1988; 27: 7 (Abstract).

Andersson R. Giant cell arteritis: Immunopathology, long term corticosteroid treatment and mortality, 1988. Thesis, University of Goteborg, Sweden.

Chuang T Y Hunder G G Listrup D M Kurland L. T. Polymyalgia rheumatica: A 10 year epidemiological and clinical study. Ann Intern Med 1982; 67: 672–80.

Andersson R. Malmvall B E Bengstsson B. A. Long term corticosteroid treatment in giant cell arteritis. Acta Med Scand 1986; 220: 465–69.

Wilkinsson I M S Russel R. W. R. Arteries of the head and neck in giant cell arteritis. Arch Neurol 1972; 27: 378–91.

Arend W P Michel B A Bloch D A . The American College of Rheumatology 1990 criteria for the classification of Takayasu's arteritis. Arthritis Rheum 1990; 33: 1129–34.

De Vita S. Neri R. Bombardieri S. Cyclophosphamide pulses in the treatment of rheumatic diseases: An update. Clin Exp Rheumatol 1991; 9: 179–93.

Bradley J D Brandt K D Katz B. P. Infectious complications of cyclophosphamide treatment for vasculitis. Arthritis Rheum 1989; 32: 45–53.

Scott D G I Bacon P A Allen C. Elson C J Wallington T. B. IgG, rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: Comparative and serial studies during cytotoxic therapy. Clin Exp Immunol 1981; 43: 54–63.

Leib E S Restivo C. Paulus H. E. Immunosuppressive corticosteroid therapy of polyarteritis nodosa. Am J Med 1979; 67: 941–47.

Williams H C Pembroke A. C. Methotrexate in the treatment of vasculitic cutaneous ulceration in rheumatoid arthritis. J R Soc Med 1989; 82: 763.

Wilne W S McKenzie A H , Methotrexate therapy in rheumatoid arthritis: Current status. Drugs 1986; 32: 103–113.

Jorizzo J. L. Behçet's disease: An update based on the 1985 International Conference in London. Arch Dermatol 1986; 122: 556–58.

Dubois E L Wallace D. J. Management of discoid and systemic lupus erythematosus. In: Wallace D J Dubois E L eds. Dubois' lupus erythematosus, third edition. Philadelphia: Lea & Febiger, 1987: 550–51.

Nicholls A. Snaith M L Maini R N Scott J. T. Controlled trial of azathioprine in rheumatoid vasculitis. Ann Rheum Dis 1973; 32: 589–91.

Yazici H. Pizarli H. Barnes E G . A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990; 322: 281–85.

Neussenblatt R B Palestine A G Chan C. C. Effectiveness of cyclosporin. A therapy for Behçet's disease. Arthritis Rheum 1985; 28: 671–79.

Borleffs J C C Derksen R H W M . Wegener's granulomatosis and cyclosporin. Transplant Proc 1988; (suppl 4): 344–45.

Guillevin L. Jarrousse B. Lok C. . Long term follow up after treatment of polyarteritis nodosa and Churg–Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomised trial of 71 patients. J Rheumatol 1991; 18: 567–74.

Furusho K. Kamiya T. Nakanoh . High dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984; ii: 1055–58.

Jayne D R W Davis M J Fox C J V Black C M Lockwood C. M. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991; 337: 1137–39.

Jayne D R W Lockwood C. M. Pooled immunoglobulin in the management of systemic vasculitis. 4th International Workshop, Lubeck, 28–30 May, 1991.

Katz S I Gallin J I Hertz K. C. Erythema elevatum diutinum: Skin and systemic manifections, immunologic studies and successful treatment with dapsone. Medicine (Baltimore) 1977; 56: 443–55.

Soto L. D. Diamino diphenylsulfone and steroids in the treatment of pyoderme gangrenosum. Int J Dermatol 1986; 167: 508–509.

Cohen M D Guisberg W. W. Polymyalgia rheumatica. Rheum Dis Clin North Am 1990; 162: 325–39.

Hamza M. H. Treatment of Behçet's disease with thalidomide. Clin Rheumatol 1986; 5: 365.

Binford C H Wayne M. Meyss M. . Leprosy JAMA 1982; 247: 2283–92.

Mizushina Y. Matzumara N. . Chemotaxis of leucocytes and colchicine treatment in Behçet's disease. J Rheumatol 1979; 6: 108.

De Merieux P. Spitler L E Paulus H. E. Treatment of Behçet's syndrome with levamisole. Arthritis Rheuma 1981; 24: 64–70.